Calcium elenolate inactivates all myxoviruses so far tested. The pH of the reaction mixture is less critical for myxovirus inactivation than that required for coxsackie A-21 virus; the myxoviruses are inactivated at a broad spectrum of pH with the maximum activity occurring at a pH below 7.0. The infectivity of the virus is more susceptible to the action of calcium elenolate than is either the neuraminidase activity or the hemagglutinin. The inactivation of Newcastle disease virus by calcium elenolate also destroys the ability of the virus to induce interferon formation in cell culture and in mice.
Calcium elenolate, a monoterpine isolated from olive extracts, is a virucidal agent that inactivates several viruses in vitro (11) , reduces the virus titer from hamsters experimentally infected with parainfluenza-3 virus (14) , and is well tolerated in rabbits and in man when given intranasally (4) . Recent studies showed that the ribonucleic acid (RNA)-dependent deoxyribonucleic acid polymerase of murine leukemia viruses is inhibited by this agent (8) . The structure and total synthesis of calcium elenolate have been described (9, 10) .
The inactivation of myxoviruses by calcium elenolate has been further studied. The spectrum of viruses has been extended so that members of most of the groups of influenza and parainfluenza viruses have been included, as well as the conditions affecting the inactivation. In addition, the effect of calcium elenolate on properties of myxoviruses other than infectivity have been investigated. The results of these studies are reported herein.
MATERIALS AND METHODS
Viruses. Influenza-A /Ann Arbor/1/57 (HIN2) was supplied by G. E. Underwood as a lyophilized allantoic fluid stock. Influenza-A /Hong Kong-Richardson/68 (H3N2) was supplied by Robert B. Couch, Baylor College of Medicine. Parainfluenza-1 (Sendai) TUC, isolated from hamsters, was supplied by M. G. Soret.
All other viruses were obtained from the American Type Culture Collection (ATCC). On receipt, each influenza virus was passed by inoculating a 1:100 dilution of the stock into the allantoic cavity of 9-to 11-day-old embryonated eggs. After 48 h at 37 C, the inoculated eggs were chilled at 4 C for 8 to 18 h and the allantoic fluids were pooled and stored at -70 C.
The parainfluenza-3 virus (C-243, HA-1) was originally obtained from the ATCC and has undergone numerous passages in these laboratories in HEP-2 cells. Parainfluenza-1 (Sendai), ATCC, was grown in embryonated eggs. Parainfluenza-1 (C-35) and parainfluenza-2 (CA virus) stocks were diluted in Hanks balanced salt solution and used to infect monkey kidney monolayers. The fluids were harvested after 48 h and used as the stock virus. Stocks of Newcastle disease virus (NDV) and vesicular stomatitis virus, Indiana strain, were supplied by G. E. Underwood and have undergone numerous passages in chicken kidney and chicken embryo cell cultures, respectively. Eagle minimal essential medium containing 3% fetal bovine serum and antibiotics (BME-3 FBS) was used for virus propagation.
Cells. Trypsinized suspensions of rhesus monkey kidney cells were purchased from Microbiological Associates, Inc. The cells on receipt were suspended in Melnicks A medium, supplemented with 2% fetal bovine serum, 0.5% anti-simian virus 5, and 0.5% antisimian virus 40 sera. Sixty-millimeter plastic petri plates (Falcon) were inoculated with 106 cells/plate and used within 1 week after planting. The techniques used to prepare monolayers of other cells have been described (11) .
Virus assays. (i) Plaque assay. Parainfluenza-3 virus was assayed by the plaque method on monolayers of HEP-2 cells as described (11) . Plaques usually form within 48 h. The influenza viruses (PR-8, NWS, and FM-1) and NDV were assayed by the plaque method on chicken kidney monolayers using previously described methods (2, 11) . Plaques usually form within 4 days.
(ii) Quantitative hemadsorption. The method used has been described by others (5, 7) . Drained monolayers of rhesus monkey kidney cells were infected with 0.5 ml of virus (37 C for 30 min). BME-3 FBS (4.5 ml) was added and the plates were incubated at 37 C for 48 to 96 h. Freshly prepared guinea pig erythrocytes (0.5% in saline) in 1.0 ml were added to each plate. The plates were incubated at 4 C for 1 h. After washing to remove the unattached erythrocytes, the adsorbed erythrocytes were lysed in 2 ml of 0.2 N NaOH and the optical density was determined at 420 nm.
(iii) Hemagglutinin (HA) titration. The method 94 has been previously described (11) . The results are expressed as the reciprocal of the dilution showing positive hemagglutination.
(iv) Neuraminidase activity. The assay was previously described (11) except that the hydrolyzed Nacetyl-neuraminic acid was estimated by the method of Warren (16) and the colored product was extracted into BuOH-HCl (1).
Interferon production and titration. (i) In vitro.
Monolayers of chicken embryo or L.2. cells were inoculated with 0.5 ml of NDV. After 60 min at 37 C, the excess virus was removed and the monolayers were fed with 5 ml of BME-3 FBS. The monolayers were incubated at 37 C for 24 h, then frozen and thawed. The resulting fluids were adjusted to pH 2 with HCl and incubated at 4 C for 3 days to destroy the infectivity of the virus. The fluids were adjusted to pH 7, and serial twofold dilutions were made in BME-3 FBS.
(ii) In vivo. Male mice (Upj: TUC [ICR] SPF) (16 to 20 g) were injected with 0.2 ml of NDV into the tail vein. Ten mice were included in each group Eight hours after injection, the blo(,d from each group of mice was harvested and pooled. The serum was separated from the clots. The interferon activity was determined using serial twofold dilutions of the serum samples.
The interferon titer was determined with vesicular stomatitis virus as the indicator virus by the plaque reduction method of Wagner (15) using either chicken embryo monolayers or L92. cells for the estimation of the interferon activity in the chicken kidney and mouse systems, respectively.
Drug. Stock solutions of calcium elenolate were prepared at 1 mg/ml in 0.9% NaCl solution. The stock solution was further diluted in saline to give the appropriate concentration. The concentrations given are those of the diluted stocks.
RESULTS
Our earlier studies (11) showed that calcium elenolate was virucidal for certain members of the myxovirus group including influenza-A (PR-8), NDV, and parainfluenza-3 virus. Since then we have extended the spectrum of myxoviruses. All of the myxoviruses so far studied (Table 1) have been found to be highly susceptible to inactivation by calcium elenolate.
The results of several experiments in which different myxoviruses have been incubated with different concentrations of calcium elenolate are shown in Table 2 . The titers given are those which remained after 30 min of incubation at 37 C. In all cases the high concentrations (1.0 and 0.5 mg/ml) of calcium elenolate destroyed all infectivity as measured by these methods. Calcium elenolate at 0.25 mg/ml inactivated 3 to 4 logs of infectivity with all viruses, and at 0.125 mg/ml the infectivity was decreased by 1.5 to 3 logs. The data show that influenza-A (PR-8) (HONI) was susceptible to calcium elenolate regardless of whether the stock was prepared in allantoic fluid or chicken embryo kidney cell culture.
The inactivation of influenza-A (PR-8), influenza-A-1 (FM-1), and parainfluenza-3 virus by calcium elenolate were studied at different pH's (Fig. 1) . The results of varying the pH of the incubation mixture with these viruses indicates that inactivation occurs more rapidly at acid pH (below 6.5) than at pH 7.0 or higher.
The rate of inactivation of influenza-A (PR-8) incubated with 0.1 mg of calcium elenolate per ml at different temperatures is shown in Fig. 2 . At 0 C very little inactivation occurred during the 2-h observation period; at 25 C, it appeared that the inactivation was somewhat more rapid initially. However, after 2 h at 25 C calcium elenolate reduced the titer by about 1.5 logs. The greatest inactivation was observed at 37 C. As with the 25 C study, the initial rate of inactivation of virus (up to 30 min) is quite rapid, i.e., about 1.5 logs of the virus was inactivated during this time. After this initial period, the reaction is somewhat slower, so that an additional 1.5 logs of virus are inactivated during the remaining 1.5 h.
The data shown in Table 3 are from a study designed to determine the effect of calcium elenolate on other properties of myxoviruses in VOL. 8, 1975 addition to their infectivity. This study extends that previously described (11) in which the infectivity of influenza virus was shown to be more susceptible to calcium elenolate than was either the HA titer or the neuraminidase activity of the virus particle. The virus titers are lower than usually encountered because the virus used in this study was grown in medium free of serum or protein. During the 30-min incubation with calcium elenolate the virus infectivity was destroyed at all concentrations of calcium elenolate greater than 0.12 mg/ml. The HA titer of the virus was destroyed at drug concentrations of 3.0 and 0.6 mg/ml; whereas at 0.12 mg/ml, the HA titer was nearly the same as the untreated control. The neuraminidase activity was about 10% of the control after incubation with 3.0 mg of calcium elenolate per ml; with lesser drug, the activity was preserved. In those samples incubated for longer time intervals (3.5 h) with calcium elenolate, the virus titer from the 0.024-mg/ml drug concentration was about 1 log less than the 30-min sample control, but the HA titer was about the same as the nondrug-treated control. Prolonged incubation for additional 3 h with 0.12 mg of calcium elenolate per ml destroyed at least 75% of the HA. The enzyme levels for all drug concentrations observed at 3.5 h were lower than the activity observed after 30 min, indicating that inactivation was due to drug and/or thermal irtactivation. After 30 min of incubation with 0.6 mg of calcium elenolate per ml, the neuraminidase activity was about 25% of the control; when the incubation was extended to 3.5 h, the activity was about 13% of the control. These data support the original observation that the infectivity of influenza-A (PR-8) is more susceptible to calcium elenolate inactivation than is either the HA or the neuraminidase activity. NDV has been used extensively to study interferon induction both in cell culture and in mice (17) . The present studies were carried out to determine the effect of calcium elenolate on the ability of NDV to induce interferon in vitro and in vivo.
NDV was incubated with different concentrations of calcium elenolate for 30 min or 3.5 h ( Table 4 ). The results indicate that, like influenza-A (PR-8), the quantity of virus inactivated is increased by increasing the incubation time. For example, incubation of NDV in the absence of drug for 3.5 h reduced the virus titer about 1 log when compared to the titer after 30 min of incubation. However, when calcium elenolate was present at 0.12 mg/ml, the titer decreased by 2.5 log during the same interval. These data also indicate that prolonged incubation with calcium elenolate, at all concentrations studied, decreases the HA titer, and further that the HA titer is dependent on the concentration of calcium elenolate. The interferon-inducing capacity of the NDV-calcium elenolate samples was tested in three systems: (i) chicken embryo where extensive virus proliferation occurs; (ii) L.29 cells where NDV growth is limited; and (iii) in mice. The data show that, in chicken embryo cells, the interferon produced is related to the infectivity of the virus; no detectable interferon could be observed in cultures which received virus that had been inactivated by calcium elenolate. As the incubation proceeded from 30 min to 3.5 h, the quantity of interferon produced decreased with decreasing infectivity. Interferon production was similarly affected in L,,29 cultures; i.e., as the infectivity of the virus decreased so did the interferon yield. The interferon titers from mice inoculated with the non-drug-treated virus was high whereas the interferon levels decreased with decreasing infectious virus. These data in all cases show that prolonged incubation of NDV with drug decreased the ability to induce inter oviruses are about four times more susceptible to inactivation by calcium elenolate than is coxsackie A-21 virus (11) . The inactivation of myxoviruses differs from coxsackie A-21 virus with regard to the effect of pH. Coxsackie A-21 inactivation requires that a slightly alkaline pH be employed for maximum inactivation (11) . Myxovirus inactivation is quite different; inactivation by calcium elenolate occurs at any pH, but maximum inactivation occurs at a slightly acid pH. Similar pH curves were obtained with parainfluenza-3, influenza-A (PR-8), and influenza-A-1 (FM-1). These data suggest that the mechanism whereby calcium elenolate inactivates picornaviruses is different from that of myxovirus inactivation.
The inactivation of influenza virus was shown to be dependent upon the temperature of the reaction mixture. Very little inactivation occurred at 4 C, whereas at 25 and 37 C the inactivation was biphasic. The initial inactivation at both temperatures appeared to be maximal for the first 30 min, then the rate of inactivation declined over the next 1.5 h. The quantity of virus inactivated was much greater at 37 than at 25 C.
It was found that the infectivity was the most susceptible of the virus properties to inactivation by calcium elenolate. HA and neuraminidase activities were also inactivated, but the concentration of drug required was greater than for inactivation of infectivity. The interferoninducing capacity of NDV was also decreased by calcium elenolate inactivation. Interferon induction in three different systems (chicken embryo, L929 cells, and mice) followed very closely the infectivity titer of the virus.
Hirschman (8) has shown that calcium elenolate inactivates the RNA-dependent deoxyribonucleic acid polymerase of murine leukemia viruses but not the deoxyribonucleic acid or RNA polymerases of E. coli B. He was unable to show that calcium elenolate interacted with DNA of calf thymus or E. coli or yeast RNA. From these studies he concluded that calcium elenolate inhibited the enzyme itself rather than the nucleic acid template. He further suggests that the inhibitory activity of calcium elenolate toward the polymerase does not depend upon non-specific binding to the protein. These data are consistent with our previous observations (11) which showed that calcium elenolate did not inactivate the infectious RNA of coxsackie A-21 virus and suggested that calcium elenolate interacts with the protein coat of the virus and thereby renders the virus incapable of entering the cell.
The interferon-inducing capability of NDV in chicken embryo cells is enhanced when the infectivity is destroyed by ultraviolet irradiation; however, continued irradiation results in a loss of interferon induction (17) . It has been suggested that a functional component of the virus particle, either the nucleic acid (3, 6, 13) or the virion-associated RNA polymerase (12) , is essential for interferon induction. In L cells or mice, interferon induction by NDV is not affected by ultraviolet irradiation (17) . In the present study, the quantity of interferon induced, in all of the systems studied, appeared to be related to the number of infectious virus particles contained in the inoculum and lend additional support to the idea that virus inactivated by calcium elenolate is incapable of entering the cell. The effect of calcium elenolate on the virion-associated RNA polymerase has not been investigated.
